
Senior hire strengthens Real Chemistry’s ability to help healthcare clients connect global strategy to nuanced needs for in-market execution

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value

Amid the formidable challenges faced by the NHS, Onyx Health delve into the pivotal role of diagnostics in healthcare transformation, showcasing how collaboration, innovation, and patient-centric approaches are revolutionising healthcare...

Experts debate ‘anomaly’ as other countries record higher death rates

Part of ongoing battle with Sanofi and Regeneron

Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe

Cinven, Advent International and Bain Capital now have opportunity to revise their bids

Values the OTC and generics specialist at €3.6bn, with offer open until 27 February

Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer
European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs